Focus on Metastatic Colorectal Cancer: Insights and Strategies to Refine Patient Care
  • Program Overview
    Focus on Metastatic Colorectal Cancer: Insights and Strategies to Refine Patient Care
    This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with metastatic CRC, featuring education enhanced by practical tools for applying new findings in the clinic. All aspects of this program are designed to complement each other, including an Interactive Treatment Decision Aid, an expert-authored module, expert commentaries, and downloadable slidesets.
  • Featured content
    In this downloadable slideset, Tanios Bekaii-Saab, MD, FACP, reviews current management strategies for patients with metastatic CRC along with key data supporting each approach.
    Date Posted: 11/21/2017
  • 1
  • 2

Latest Content

7 of 7 Shown
  • Q&A From a New Mother With Metastatic Colon Cancer: My Management of the Case and Follow-up

    Alan P. Venook MD - 1/11/2018 2 comments / Last Comment: 1/25/2018
    In this case study from my clinic on the treatment of a new mother with metastatic colon cancer, I explore her questions, options, therapy selection, and follow-up.
  • Learning Module cme-icon ce-icon

    Therapy Selection in Metastatic Colorectal Cancer

    In this CME/CE-certified activity, Tanios Bekaii-Saab, MD, FACP, reviews key data supporting evolving treatment choices for patients with metastatic colorectal cancer.
    Faculty: Tanios Bekaii-Saab MD, FACP
    Released: 11/21/2017
  • Downloadable Slides: Therapy Selection in Metastatic Colorectal Cancer

    In this downloadable slideset, Tanios Bekaii-Saab, MD, FACP, reviews current management strategies for patients with metastatic CRC along with key data supporting each approach.
    Date Posted: 11/21/2017
  • Metastatic Colorectal Cancer: Areas of Consensus and Controversy Among Experts

    Tanios Bekaii-Saab MD, FACP - 10/31/2017 6 comments / Last Comment: 2/6/2018
    In this commentary on the treatment of metastatic colorectal cancer, I explore areas of consensus and controversy among experts including management of MSI-high/MMR-deficient tumors, treatment of transverse primaries, management of tumors with BRAF V600E mutations, and approaches in later lines of therapy.
  • Focus on Metastatic Colorectal Cancer: An Interactive Decision Support Tool

    This interactive treatment decision aid will let you compare your choice of therapy for patients with metastatic CRC with expert recommendations from Tanios Bekaii-Saab, MD, FACP; George A. Fisher, MD, PhD; Scott Kopetz, MD, PhD, FACP; John Strickler, MD; and Alan P. Venook, MD.
    Date Posted: 10/17/2017
  • How I Manage Patients With Chemotherapy-Refractory Metastatic CRC

    John Strickler MD - 9/11/2017 18 comments / Last Comment: 2/6/2018
    As patients progress through first-line and second-line therapy, selection of therapy becomes more complicated and nuanced. Here’s how I navigate the multiple treatment options.
  • Combination Therapy With BRAF Inhibitors: A New Frontier in BRAF-Mutant CRC

    Scott Kopetz MD, PhD, FACP - 8/14/2017 10 comments / Last Comment: 1/29/2018
    BRAF-mutated CRC has a poor prognosis and limited treatment options. Read my thoughts on how combinations with BRAF inhibitors are offering promising benefits for this challenging population.
7 of 7 Shown
Show 0 More
Loading...